U.S. Semiconductors Stock News

Jumia Technologies AG reported third-quarter 2025 earnings, with sales rising to US$45.63 million from US$36.43 million a year earlier, but the net loss widened to US$17.94 million from US$16.9 million for the same period. While revenue expanded at a strong pace, the company also showed improved operational efficiency as seen in a 17% better adjusted EBITDA loss and a substantial narrowing of losses for the nine-month period. We'll explore how Jumia's significant revenue growth and improved...

Vertex Pharmaceuticals recently reported positive interim data from the RUBY-3 trial at ASN Kidney Week 2025, showing that its investigational kidney disease therapy povetacicept led to substantial reductions in proteinuria and favorable safety results in adults with IgA nephropathy and primary membranous nephropathy. Alongside these clinical findings, Vertex received Breakthrough Therapy Designation from the FDA for povetacicept in IgA nephropathy, completed late-stage trial enrollment, and...

Precigen (PGEN) just released its Q3 earnings, drawing attention from investors with revenue rising to $2.92 million compared to the same period last year. However, net losses expanded significantly. See our latest analysis for Precigen. Following the release of Precigen’s third quarter earnings, the share price has shown remarkable momentum, with a 1-month share price return of 20.62% and a tremendous year-to-date gain of 257.41%. While the expanded net loss may have rattled some nerves,...

Curious if Bloom Energy’s rapid ascent means it is now overvalued, or if there is real substance behind the hype? Let’s break down what has happened and what really matters for investors looking for value. Bloom Energy’s stock has had a rollercoaster year, rocketing up an incredible 343.1% year-to-date and 679.7% over the past year. However, it recently pulled back with a 24.3% drop in the last week. Momentum picked up following policy updates on clean energy incentives and major federal...

Agilent Technologies (A) shares recently caught the attention of investors following a move in the broader pharmaceuticals and biotech sector. The company has delivered solid annual revenue and net income growth, even as short-term returns remain mixed. See our latest analysis for Agilent Technologies. After a robust rally throughout the past quarter, Agilent's share price has cooled slightly in the last week, settling at $146.89. Despite this short-term pause, momentum remains positive for...

Wondering if AeroVironment is a hidden gem or priced to perfection? You are not alone, as plenty of investors are eyeing its recent action for signs of value. The stock's seen a wild ride: after surging an impressive 88.9% year-to-date, it has pulled back by 10.0% in the last week and an even bigger 26.4% over the past month. Recent headlines have spotlighted AeroVironment's expanding role in global defense and innovative unmanned systems, fueling optimism on one hand but also heightening...

Ever wondered if Universal Display's recent slide might finally signal a fair price or even a hidden bargain? Let's explore what is really driving the stock's current value and whether it might be time to take a closer look. The stock has had a rough run lately, falling 13.5% in the past week and down 28.9% over the past year. This may have caught the eye of value-focused investors seeking opportunity in volatile markets. Some of this recent drop follows news about broader tech sector...

IMAX Corporation recently completed a fixed-income offering of US$220 million in 0.75% senior unsecured convertible notes due November 15, 2030, with features including callability and conversion rights. This move gives the company fresh capital while raising potential for future share dilution due to the convertible nature of the notes. We’ll examine how the issuance of convertible notes factors into IMAX’s capital structure, growth flexibility, and possible dilution risk. AI is about to...

Cohen & Steers (CNS) shares have faced some pressure lately, with the stock slipping over the past quarter. Investors are now paying close attention to recent trends to gauge the company’s next move. See our latest analysis for Cohen & Steers. After a steady drop earlier in the year, Cohen & Steers’ momentum has continued to fade. The latest share price closed at $65.49, and the year-to-date share price return now sits at a challenging -28.32%. Looking at the bigger picture, the stock’s...

First American Financial (FAF) just delivered some good news for shareholders, with third quarter results showing a strong 41% jump in revenue year over year and a return to profitability. The company also kept its 15-year streak of growing dividends going by declaring its regular cash payout, signaling that management remains confident about the firm’s future direction. See our latest analysis for First American Financial. Alongside the recent board appointment of seasoned insurance leader...

Best Buy (BBY) shares have seen some movement lately, catching the attention of investors who are watching retail stocks closely. Interest is piqued as the company’s stock trends are measured in comparison to broader sector changes. See our latest analysis for Best Buy. After a challenging start to the year, Best Buy’s recent share price movement hints at a shift in sentiment. The stock has climbed 6.4% over the past 90 days, though its year-to-date share price return remains negative, and...

Thinking about whether W. R. Berkley is a solid buy right now? If you are curious about the real value behind the stock price, you are in the right place. W. R. Berkley’s shares have climbed 32.7% year-to-date and surged 31.6% over the past year, with a steady gain of 3.2% in just the last week. This comes even after a mild pullback of -1.9% in the past month. This momentum has sparked interest among investors, especially as the insurance sector faces ongoing shifts in industry risk and some...

Castle Biosciences (CSTL) drew attention with a busy announcement day, unveiling third quarter results, raising its full-year revenue outlook for 2025, and launching a new gene expression test for atopic dermatitis. See our latest analysis for Castle Biosciences. It’s been a lively period for Castle Biosciences, with the share price up an impressive 52.6% over the last month and gaining nearly 70% in the past 90 days. This strong momentum follows the raised revenue outlook and the launch of...

JD.com recently completed a share repurchase of 80,900,000 shares for US$1.5 billion and reported third-quarter revenue of ¥299.06 billion, up from ¥260.39 billion the previous year, despite a sharp fall in net income to ¥5.28 billion. While the company posted record user orders and revenue growth during its Singles’ Day event, the sharp decline in net income and ongoing pressure on margins have kept analyst outlooks mixed. We'll explore how JD.com's strong Singles’ Day sales and quarterly...

Earlier this week, NFI announced an expanded partnership with Triumph Financial, integrating Triumph’s Payment, Audit, and Intelligence solutions across its carrier network to accelerate payments, automate invoice audits, and improve operational efficiency. This move further embeds Triumph’s technology within a major freight network, strengthening its position in freight fintech and highlighting growing client demand for advanced, data-driven transaction solutions. We'll explore how the...

If you've ever wondered whether Goldman Sachs Group is trading at a bargain, you're in the right place. We're diving deep into what moves its value and what those numbers might really mean for investors. The stock has kept momentum, jumping 2.3% over the past week and climbing a hefty 40.1% year-to-date. This has sparked fresh conversations about its growth prospects and shifting risk profile. Recent headlines point to strategic moves in wealth management and investment banking, with market...

Warrior Met Coal (HCC) just raised its full-year 2025 production and sales guidance by about 10%, signaling greater confidence in ongoing operations. The update follows the company's third quarter earnings announcement. See our latest analysis for Warrior Met Coal. Despite some earnings volatility in recent quarters, Warrior Met Coal has seen strong momentum build over the past few months. The company has achieved a 34% share price return in the last 90 days and a 19.6% surge over the past...

Apollo Global Management (APO) just delivered third-quarter results that topped expectations, with both fee-related and spread-related earnings reaching new highs. Management pointed to growing private asset demand as a key factor boosting origination and future growth. See our latest analysis for Apollo Global Management. Even with Apollo Global Management’s upbeat earnings and moves like the majority stake in Atlético de Madrid, the stock hasn’t yet found its stride. Its 1-year total...

Wondering if Archer Aviation stock is undervalued right now? You are not alone, especially with all the buzz about its future and its wild share price ride. Despite a rough patch recently, with shares dropping 10.4% over the past week and nearly 39% over the past month, Archer has soared 85.5% in the past year and an eye-popping 213.4% over the past three years. This hints at both opportunity and volatility. Much of the recent excitement (and anxiety) around the stock has been fueled by...

Ardelyx, Inc. recently presented results from the first real-world study of XPHOZAH, its FDA-approved phosphate absorption inhibitor for adults with chronic kidney disease on dialysis, at the American Society of Nephrology's Kidney Week in Houston. This announcement shines a light on XPHOZAH’s unique mechanism of action and its role as the only phosphate absorption inhibitor in its class, potentially broadening treatment options for patients who do not respond to standard phosphate...

AECOM (NYSE:ACM), together with Jacobs, has been selected to provide design services for The Mukaab, the ambitious centerpiece of Riyadh's New Murabba development. This milestone initiative supports Saudi Arabia’s Vision 2030 for innovative urban transformation. See our latest analysis for AECOM. In the weeks leading up to this high-profile win, AECOM's share price has shown solid momentum, up nearly 12% in the past 90 days and delivering a strong 26% total shareholder return over the last...

JFrog (FROG) stock has been on the move, showing a month of gains and catching attention from investors interested in the company's performance trends. With steady revenue growth and a strong year to date rally, some are re-evaluating its outlook. See our latest analysis for JFrog. Momentum is clearly building for JFrog, with a run of strong share price returns over the past month and year to date that point to growing investor confidence. The stock’s 1-year total shareholder return of 89.2%...

Nurix Therapeutics recently appointed Roger Dansey, M.D., a seasoned leader in oncology drug development with prior roles at Pfizer Oncology and Seagen, to its board of directors and presented new clinical data on its investigational CBL-B inhibitor, NX-1607, at the SITC 2025 Annual Meeting. The addition of Dr. Dansey is expected to further strengthen Nurix’s clinical and regulatory expertise as the company advances its oncology pipeline, including pivotal development programs. We'll explore...

Universal Corporation recently reported improved second quarter and first-half fiscal 2026 results, highlighted by higher sales and net income, alongside the appointment of Tatiana Santos Godoi as Chief Human Resources Officer and Gregory A. Trojan to the Board of Directors. The company’s latest results indicate solid performance across both the Tobacco and Ingredients segments, with management signaling confidence in its ability to handle shifting market dynamics such as an anticipated...